Related references
Note: Only part of the references are listed.Comprehensive Review of Molecular Mechanisms and Clinical Features of Invasive Lobular Cancer
Nikhil Pramod et al.
ONCOLOGIST (2021)
Molecular Classification of Breast Cancer
Julia Y. S. Tsang et al.
ADVANCES IN ANATOMIC PATHOLOGY (2020)
Breast cancer prevention in high-risk women
Mangesh A. Thorat et al.
BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY (2020)
Overcoming Taxol-resistance in A549 cells: A comprehensive strategy of targeting P-gp transporter, AKT/ERK pathways, and cytochrome P450 enzyme CYP1B1 by 4-hydroxyemodin
Hao Lin et al.
BIOCHEMICAL PHARMACOLOGY (2020)
Emerging role of tumor-related functional peptides encoded by lncRNA and circRNA
Pan Wu et al.
MOLECULAR CANCER (2020)
Long non-coding RNA NEAT1-centric gene regulation
Ziqiang Wang et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2020)
Targeting DNA Repair in Ovarian Cancer Treatment Resistance
M. W. Wong-Brown et al.
CLINICAL ONCOLOGY (2020)
LncRNA NEAT1 Interacted With DNMT1 to Regulate Malignant Phenotype of Cancer Cell and Cytotoxic T Cell Infiltration via Epigenetic Inhibition of p53, cGAS, and STING in Lung Cancer
Fang Ma et al.
FRONTIERS IN GENETICS (2020)
Targeting Glucose Metabolism to Overcome Resistance to Anticancer Chemotherapy in Breast Cancer
Elizabeth Varghese et al.
CANCERS (2020)
FOXA1 Mutations Reveal Distinct Chromatin Profiles and Influence Therapeutic Response in Breast Cancer
Amaia Arruabarrena-Aristorena et al.
CANCER CELL (2020)
Toosendanin induces apoptosis of MKN-45 human gastric cancer cells partly through miR-23a-3p-mediated downregulation ofBCL2
Shuli Shao et al.
MOLECULAR MEDICINE REPORTS (2020)
Progress in research on paclitaxel and tumor immunotherapy
Linyan Zhu et al.
CELLULAR & MOLECULAR BIOLOGY LETTERS (2019)
NEAT1 promotes colon cancer progression through sponging miR-495-3p and activating CDK6 in vitro and in vivo
Zhiyun He et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
FOXA1 mutations alter pioneering activity, differentiation and prostate cancer phenotypes
Elizabeth J. Adams et al.
NATURE (2019)
NEAT1/miR-23a-3p/KLF3: a novel regulatory axis in melanoma cancer progression
Fei Ding et al.
CANCER CELL INTERNATIONAL (2019)
RNA Pull-down Procedure to Identify RNA Targets of a Long Non-coding RNA
Manon Torres et al.
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2018)
Systematic analysis of lncRNA-miRNA-mRNA competing endogenous RNA network identifies four-lncRNA signature as a prognostic biomarker for breast cancer
Chun-Ni Fan et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2018)
NEAT1_2-SFPQ axis mediates cisplatin resistance in liver cancer cells in vitro
Yi Ru et al.
ONCOTARGETS AND THERAPY (2018)
LncRNA NEAT1 Regulates Cell Viability and Invasion in Esophageal Squamous Cell Carcinoma through the miR-129/CTBP2 Axis
Yong Li et al.
DISEASE MARKERS (2017)
Silencing of glutaminase 1 resensitizes Taxol-resistant breast cancer cells to Taxol
Aiqin Fu et al.
MOLECULAR MEDICINE REPORTS (2015)
MicroRNA-212 suppresses tumor growth of human hepatocellular carcinoma by targeting FOXA1
Changwei Dou et al.
ONCOTARGET (2015)
Tumor suppressor long non-coding RNA, MT1DP is negatively regulated by YAP and Runx2 to inhibit FoxA1 in liver cancer cells
Wenjun Yu et al.
CELLULAR SIGNALLING (2014)
FOXA1 represses the molecular phenotype of basal breast cancer cells
G. M. Bernardo et al.
ONCOGENE (2013)
Microtubules and resistance to tubulin-binding agents
Maria Kavallaris
NATURE REVIEWS CANCER (2010)
MYC-Induced Cancer Cell Energy Metabolism and Therapeutic Opportunities
Chi V. Dang et al.
CLINICAL CANCER RESEARCH (2009)
Share Paper
